or
Remember me
Back
Suggestion to IR. Start building a more robust, citation heavy case around the function, value and benefit of sortilin. It's an unknown target but there is tons of highly detailed academic studies pointing to its value and prospective moth as an oncology target. Start the education process.
A daily snapshot of everything from market open to close.